Drug Patents owned by Redhill

1. Drug name - AEMCOLO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8263120 REDHILL Oral antimicrobial pharmaceutical compositions
May, 2025

(2 years from now)

US8486446 REDHILL Oral antimicrobial pharmaceutical compositions
May, 2025

(2 years from now)

US8741948 REDHILL Oral antimicrobial pharmaceutical compositions
May, 2025

(2 years from now)

US8529945 REDHILL Oral antimicrobial pharmaceutical compositions
May, 2025

(2 years from now)

Exclusivity Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Nov 16, 2023
Generating Antibiotic Incentives Now (GAIN) Nov 16, 2028

Drugs and Companies using RIFAMYCIN SODIUM ingredient

Market Authorisation Date: 16 November, 2018

Treatment: Treatment of travelers' diarrhea caused by non-invasive strains of escherichia coli in adults

Dosage: TABLET, DELAYED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 194MG BASE TABLET, DELAYED RELEASE;ORAL Prescription

2. Drug name - MOVANTIK

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7662365 REDHILL Polymer conjugates of opioid antagonists
Oct, 2022

(a month ago)

US7786133 REDHILL Chemically modified small molecules
Sep, 2028

(5 years from now)

US9012469 REDHILL Crystalline naloxol-peg conjugate
Apr, 2032

(9 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8617530 REDHILL Polymer conjugates of opioid antagonists
Oct, 2022

(a month ago)

US7056500 REDHILL Polymer conjugates of opioid antagonists
Jun, 2024

(1 year, 6 months from now)

US8067431 REDHILL Chemically modified small molecules
Dec, 2024

(2 years from now)

Drugs and Companies using NALOXEGOL OXALATE ingredient

Market Authorisation Date: 16 September, 2014

Treatment: Treatment of opioid-induced constipation

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 12.5MG BASE TABLET;ORAL Prescription
EQ 25MG BASE TABLET;ORAL Prescription

3. Drug name - TALICIA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10238606 REDHILL Pharmaceutical compositions for the treatment of Helicobacter pylori
Feb, 2034

(11 years from now)

US11135172 REDHILL Rifabutin-based compositions and methods for treating Helicobacter pylori infection
Feb, 2034

(11 years from now)

US9050263 REDHILL Pharmaceutical compositions for the treatment of Helicobacter pylori
Feb, 2034

(11 years from now)

US9498445 REDHILL Pharmaceutical compositions for the treatment of Helicobacter pylori
Feb, 2034

(11 years from now)

US9603806 REDHILL Pharmaceutical compositions for the treatment of Helicobacter pylori
Feb, 2034

(11 years from now)

Drugs and Companies using AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN ingredient

Market Authorisation Date: 01 November, 2019

Treatment: Treatment of h. pylori infection in adults

Dosage: CAPSULE, DELAYED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
250MG;EQ 10MG BASE;12.5MG CAPSULE, DELAYED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.

Other things you might be interested in